Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

被引：0

作者：

Thongprasert, Sumitra ^{[1
]}

Boldeanu, Cosmin ^{[2
]}

Radosavljevic, Davorin ^{[3
]}

Petrovic, Marina ^{[4
]}

Jones, Hilary ^{[5
]}

Cseh, Agnieszka ^{[6
]}

Gaafar, Rabab ^{[7
]}

机构：

[1] Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand

[2] Braila Cty Emergency Hosp, Braila, Romania

[3] Inst Oncol & Radiol Serbia, Belgrade, Serbia

[4] Clin Ctr Kragujevac, Kragujevac, Serbia

[5] Boehringer Ingelheim Ltd, Dept Oncol, Bracknell, Berks, England

[6] Boehringer Ingelheim Rcv Gmbh & Co Kg, Dept Oncol, Vienna, Austria

[7] Cairo Univ, Natl Canc Inst, Cairo, Egypt

来源：

关键词：

afatinib; NSCLC; EGFR mutated; Second-line;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-088

引用

页码：S667 / S667

页数：1